ROIs Derived from microPET Images of Animals Given Pretargeted 124I-IMP-325 or 124I-Humanized Anti-CEA Fab′
Activity/volume (mean ± SD) | Tumor/ kidney ratio | ||
---|---|---|---|
Animal/time | Tumor | Kidney | |
Pretargeted 124I-IMP-325 | |||
Animal 1 (tumor, 0.448 g) | |||
1.9 h | 2.58 ± 1.09 | 1.11 ± 0.24 | 2.3 |
6.3 h | 2.44 ± 1.24 | 0.92 ± 0.23 | 2.6 |
24 h | 2.44 ± 1.20 | 0.55 ± 0.24 | 4.4 |
Animal 2 (tumor, 0.483 g) | |||
2.7 h | 1.82 ± 0.67 | 0.89 ± 0.38 | 2.0 |
6.4 h | 1.67 ± 0.68 | 0.71 ± 0.26 | 2.4 |
25 h | 1.85 ± 0.64 | 0.44 ± 0.16 | 4.2 |
Animal 3 (tumor, 0.285 g) | |||
2.1 h | 2.06 ± 0.75 | 0.70 ± 0.25 | 2.9 |
5.8 h | 1.89 ± 0.76 | 0.44 ± 0.19 | 4.3 |
25 h | 1.90 ± 0.70 | 0.29 ± 0.08 | 6.6 |
124I-Anti-CEA Fab′ | |||
Animal 1 (tumor, 0.596 g) | |||
2.1 h | 1.77 ± 0.41 | 11.28 ± 2.86 | 0.16 |
6.5 h | 1.76 ± 0.43 | 3.85 ± 0.53 | 0.46 |
26 h | 0.49 ± 0.09 | 0.09 ± 0.05 | 5.44 |
Animal 2 (tumor, 0.173 g) | |||
1.8 h | 1.07 ± 0.49 | 8.14 ± 2.73 | 0.10 |
6.5 h | 0.71 ± 0.33 | 1.68 ± 0.48 | 0.42 |
27 h | 0.17 ± 0.09 | 0.10 ± 0.05 | 1.7 |
Animal 3 (tumor, 0.280 g) | |||
2.9 h | 1.84 ± 0.58 | 10.33 ± 3.22 | 0.18 |
6.6 h | 1.03 ± 0.39 | 1.42 ± 0.70 | 0.73 |
27 h | 0.36 ± 0.12 | 0.09 ± 0.04 | 4.00 |